The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers

ConclusionSGLT-2i in KTR is not associated with an increased risk of genital infection and UTI in diabetic KTR, even in the early posttransplant period. The use of SGLT-2i reduces proteinuria in KTR and has no adverse effects on allograft function at the 12-month follow-up.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research